Literature DB >> 24352472

Hepatitis C virus stimulates low-density lipoprotein receptor expression to facilitate viral propagation.

Gulam Hussain Syed1, Huihui Tang, Mohsin Khan, Tarek Hassanein, Jingwen Liu, Aleem Siddiqui.   

Abstract

UNLABELLED: Lipids play a crucial role in multiple aspects of hepatitis C virus (HCV) life cycle. HCV modulates host lipid metabolism to enrich the intracellular milieu with lipids to facilitate its proliferation. However, very little is known about the influence of HCV on lipid uptake from bloodstream. Low-density lipoprotein receptor (LDLR) is involved in uptake of cholesterol rich low-density lipoprotein (LDL) particles from the bloodstream. The association of HCV particles with lipoproteins implicates their role in HCV entry; however, the precise role of LDLR in HCV entry still remains controversial. Here, we investigate the effect of HCV infection on LDLR expression and the underlying mechanism(s) involved. We demonstrate that HCV stimulates LDLR expression in both HCV-infected Huh7 cells and in liver tissue from chronic hepatitis C patients. Fluorescence activated cell sorting and immunofluorescence analysis revealed enhanced cell surface and total expression of LDLR in HCV-infected cells. Increased LDLR expression resulted in the enhanced uptake of lipoprotein particles by HCV-infected cells. Analysis of LDLR gene promoter identified a pivotal role of sterol-regulatory element binding proteins (SREBPs), in the HCV-mediated stimulation of LDLR transcription. In addition, HCV negatively modulated the expression of proprotein convertase subtilisin/kexin type 9 (PCSK9), a protein that facilitates LDLR degradation. Ectopic expression of wild-type PCSK9 or gain-of-function PCSK9 mutant negatively affected HCV replication. Overall, our results demonstrate that HCV regulates LDLR expression at transcriptional and posttranslational level via SREBPs and PCSK9 to promote lipid uptake and facilitate viral proliferation. IMPORTANCE: HCV modulates host lipid metabolism to promote enrichment of lipids in intracellular environment, which are essential in multiple aspects of HCV life cycle. However, very little is known about the influence of HCV on lipid uptake from the bloodstream. LDLR is involved in uptake of cholesterol rich lipid particles from bloodstream. In this study, we investigated the effect of HCV on LDLR expression and the underlying mechanism triggered by the virus to modulate LDLR expression. Our observations suggest that HCV upregulates LDLR expression at both the protein and the transcript levels and that this upregulation likely contributes toward the uptake of serum lipids by infected hepatocytes. Abrogation of HCV-mediated upregulation of LDLR inhibits serum lipid uptake and thereby perturbs HCV replication. Overall, our findings highlight the importance of serum lipid uptake by infected hepatocytes in HCV life cycle.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24352472      PMCID: PMC3958050          DOI: 10.1128/JVI.02727-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

Review 1.  Receptor-mediated mechanisms of lipoprotein remnant catabolism.

Authors:  D A Chappell; J D Medh
Journal:  Prog Lipid Res       Date:  1998-12       Impact factor: 16.195

2.  Protein kinase D negatively regulates hepatitis C virus secretion through phosphorylation of oxysterol-binding protein and ceramide transfer protein.

Authors:  Yutaka Amako; Gulam H Syed; Aleem Siddiqui
Journal:  J Biol Chem       Date:  2011-02-01       Impact factor: 5.157

3.  Effects of hypolipidemic agent nordihydroguaiaretic acid on lipid droplets and hepatitis C virus.

Authors:  Gulam H Syed; Aleem Siddiqui
Journal:  Hepatology       Date:  2011-12       Impact factor: 17.425

4.  Identification of a novel sterol-independent regulatory element in the human low density lipoprotein receptor promoter.

Authors:  J Liu; T E Ahlborn; M R Briggs; F B Kraemer
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

5.  Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment.

Authors:  Kara N Maxwell; Edward A Fisher; Jan L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-27       Impact factor: 11.205

6.  Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes.

Authors:  Jay D Horton; Nila A Shah; Janet A Warrington; Norma N Anderson; Sahng Wook Park; Michael S Brown; Joseph L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-25       Impact factor: 11.205

7.  Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.

Authors:  Jean Michel Petit; Muriel Benichou; Laurence Duvillard; Valerie Jooste; Jean Baptiste Bour; Anne Minello; Bruno Verges; Jean Marcel Brun; Philippe Gambert; Patrick Hillon
Journal:  Am J Gastroenterol       Date:  2003-05       Impact factor: 10.864

8.  LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor.

Authors:  Noam Zelcer; Cynthia Hong; Rima Boyadjian; Peter Tontonoz
Journal:  Science       Date:  2009-06-11       Impact factor: 47.728

9.  Hepatitis C virus infection activates an innate pathway involving IKK-α in lipogenesis and viral assembly.

Authors:  Qisheng Li; Véronique Pène; Siddharth Krishnamurthy; Helen Cha; T Jake Liang
Journal:  Nat Med       Date:  2013-05-26       Impact factor: 53.440

10.  c-IAP1 binds and processes PCSK9 protein: linking the c-IAP1 in a TNF-α pathway to PCSK9-mediated LDLR degradation pathway.

Authors:  Weiming Xu; Lizhi Liu; David Hornby
Journal:  Molecules       Date:  2012-10-15       Impact factor: 4.411

View more
  35 in total

1.  MicroRNAs regulate the immunometabolic response to viral infection in the liver.

Authors:  Ragunath Singaravelu; Shifawn O'Hara; Daniel M Jones; Ran Chen; Nathan G Taylor; Prashanth Srinivasan; Curtis Quan; Dominic G Roy; Rineke H Steenbergen; Anil Kumar; Rodney K Lyn; Dennis Özcelik; Yanouchka Rouleau; My-Anh Nguyen; Katey J Rayner; Tom C Hobman; David Lorne Tyrrell; Rodney S Russell; John Paul Pezacki
Journal:  Nat Chem Biol       Date:  2015-10-19       Impact factor: 15.040

Review 2.  Biology of proprotein convertase subtilisin kexin 9: beyond low-density lipoprotein cholesterol lowering.

Authors:  Giuseppe Danilo Norata; Hagai Tavori; Angela Pirillo; Sergio Fazio; Alberico L Catapano
Journal:  Cardiovasc Res       Date:  2016-08-05       Impact factor: 10.787

3.  New Mechanism of Hepatic Fibrogenesis: Hepatitis C Virus Infection Induces Transforming Growth Factor β1 Production through Glucose-Regulated Protein 94.

Authors:  Min Hyeok Jee; Ka Young Hong; Ji Hoon Park; Jae Seung Lee; Hee Sun Kim; Song Hee Lee; Sung Key Jang
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

Review 4.  Hepatitis C virus relies on lipoproteins for its life cycle.

Authors:  Germana Grassi; Giorgia Di Caprio; Gian Maria Fimia; Giuseppe Ippolito; Marco Tripodi; Tonino Alonzi
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

Review 5.  Lipid dysregulation in hepatitis C virus, and impact of statin therapy upon clinical outcomes.

Authors:  Tracey G Simon; Adeel A Butt
Journal:  World J Gastroenterol       Date:  2015-07-21       Impact factor: 5.742

Review 6.  Interaction of pathogens with host cholesterol metabolism.

Authors:  Dmitri Sviridov; Michael Bukrinsky
Journal:  Curr Opin Lipidol       Date:  2014-10       Impact factor: 4.776

7.  Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1-infected patients.

Authors:  Eric G Meissner; Yu-Jin Lee; Anu Osinusi; Zayani Sims; Jing Qin; Dan Sturdevant; John McHutchison; Mani Subramanian; Maureen Sampson; Susanna Naggie; Keyur Patel; Alan T Remaley; Henry Masur; Shyam Kottilil
Journal:  Hepatology       Date:  2015-01-28       Impact factor: 17.425

Review 8.  Roles of lipoprotein receptors in the entry of hepatitis C virus.

Authors:  Jingya Lyu; Hitomi Imachi; Kensaku Fukunaga; Takuo Yoshimoto; Huanxiang Zhang; Koji Murao
Journal:  World J Hepatol       Date:  2015-10-28

9.  Association of Serum Lipids with Hepatic Steatosis, Stage of Liver Fibrosis and Viral Load in Chronic Hepatitis C.

Authors:  Ivan Valkov; Radina Ivanova; Assen Alexiev; Krasimir Antonov; Lyudmila Mateva
Journal:  J Clin Diagn Res       Date:  2017-08-01

10.  Low-density lipoprotein receptor genetic polymorphism in chronic hepatitis C virus Egyptian patients affects treatment response.

Authors:  Mazen Naga; Mona Amin; Dina Algendy; Ahmed Elbadry; May Fawzi; Ayman Foda; Serag Esmat; Dina Sabry; Laila Rashed; Samia Gabal; Manal Kamal
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.